Argenica Therapeutics Limited (AGN.AX)
AUD 0.68
(0.0%)
AUD 0.68
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 8.26 Million AUD | 24.82% |
| 2023 | 6.62 Million AUD | 52.24% |
| 2022 | 4.35 Million AUD | 228.24% |
| 2021 | 1.32 Million AUD | 245.55% |
| 2020 | 383.65 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 2.22 Million AUD | -41.58% |
| 2024 Q4 | 2.22 Million AUD | 0.0% |
| 2024 FY | 8.26 Million AUD | 24.82% |
| 2024 Q2 | 3.81 Million AUD | 100.0% |
| 2024 Q1 | 1.9 Million AUD | -48.11% |
| 2023 Q2 | 2.94 Million AUD | 100.0% |
| 2023 FY | 6.62 Million AUD | 52.24% |
| 2023 Q4 | 3.67 Million AUD | 100.0% |
| 2023 Q3 | 1.83 Million AUD | -37.71% |
| 2023 Q1 | 1.47 Million AUD | -37.12% |
| 2022 FY | 4.35 Million AUD | 228.24% |
| 2022 Q3 | 1.17 Million AUD | -41.52% |
| 2022 Q2 | 2 Million AUD | 100.0% |
| 2022 Q1 | 1 Million AUD | -8.4% |
| 2022 Q4 | 2.34 Million AUD | 100.0% |
| 2021 FY | 1.32 Million AUD | 245.55% |
| 2021 Q2 | 230.84 Thousand AUD | 100.0% |
| 2021 Q4 | 1.09 Million AUD | 100.0% |
| 2021 Q1 | 115.42 Thousand AUD | -69.9% |
| 2021 Q3 | 547.43 Thousand AUD | 137.15% |
| 2020 Q2 | 200.00 AUD | 0.0% |
| 2020 FY | 383.65 Thousand AUD | 0.0% |
| 2020 Q4 | 383.45 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdAlta Limited | 6.76 Million AUD | -22.153% |
| Acrux Limited | 8.55 Million AUD | 3.285% |
| Actinogen Medical Limited | 22.77 Million AUD | 63.685% |
| AnteoTech Limited | 12.18 Million AUD | 32.148% |
| Arovella Therapeutics Limited | 10.78 Million AUD | 23.329% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -1064.312% |
| Alterity Therapeutics Limited | 23.4 Million AUD | 64.672% |
| Amplia Therapeutics Limited | 8.43 Million AUD | 1.975% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -81.924% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -199.497% |
| Biome Australia Limited | 7.91 Million AUD | -4.524% |
| Biotron Limited | 5.11 Million AUD | -61.801% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -1274.022% |
| BTC Health Limited | -1.03 Million AUD | 895.931% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | 58.168% |
| CSL Limited | 7.56 Billion AUD | 99.891% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | 85.314% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | 73.579% |
| Cynata Therapeutics Limited | 11.12 Million AUD | 25.661% |
| Dimerix Limited | 25.64 Million AUD | 67.753% |
| EZZ Life Science Holdings Limited | 39.57 Million AUD | 79.105% |
| Hexima Limited | 1 Million AUD | -719.741% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -100.447% |
| Immuron Limited | 9.13 Million AUD | 9.507% |
| Immutep Limited | 42.87 Million AUD | 80.713% |
| Imugene Limited | 135.09 Million AUD | 93.879% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -147.144% |
| Memphasys Limited | 3.67 Million AUD | -124.804% |
| Nanollose Limited | 12.5 Thousand AUD | -66047.836% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | 74.71% |
| Noxopharm Limited | 7 Million AUD | -18.127% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -320.774% |
| Nyrada Inc. | 4.55 Million AUD | -81.533% |
| Orthocell Limited | 15.36 Million AUD | 46.198% |
| PharmAust Limited | 6.65 Million AUD | -24.217% |
| Patrys Limited | 4.93 Million AUD | -67.618% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 87.298% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -826.885% |
| Prescient Therapeutics Limited | 10.89 Million AUD | 24.128% |
| PYC Therapeutics Limited | 60.91 Million AUD | 86.425% |
| Race Oncology Limited | 14.77 Million AUD | 44.016% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -2663.492% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | 61.866% |
| Starpharma Holdings Limited | 22.81 Million AUD | 63.757% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 96.929% |
| Tissue Repair Ltd | 6.66 Million AUD | -24.034% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -39.012% |